CAS 314761-14-3

Fórmula: C21H14N6OS2

InChI: InChI=1S/C21H14N6OS2/c28-19-18(24-25-20-22-11-12-29-20)17(15-9-5-2-6-10-15)26-27(19)21-23-16(13-30-21)14-7-3-1-4-8-14/h1-13,26H

Chave InChI: CTRCXGFSYFTJIW-UHFFFAOYSA-N

SMILES: C1=CC=C(C=C1)C2=CSC(=N2)N3C(=O)C(=C(N3)C4=CC=CC=C4)N=NC5=NC=CS5

BTSA1

CAS: 314761-14-3

Fórmula: C₂₁H₁₄N₆OS₂

Pureza: 98%

Cor e Forma: Solid

Peso molecular: 430.5055

Ref: IN-DA01DQAP

5-Phenyl-2-(4-Phenylthiazol-2-Yl)-4-(2-(Thiazol-2-Yl)Hydrazono)-2,4-Dihydro-3H-Pyrazol-3-One

CAS: 314761-14-3

5-Phenyl-2-(4-Phenylthiazol-2-Yl)-4-(2-(Thiazol-2-Yl)Hydrazono)-2,4-Dihydro-3H-Pyrazol-3-One

Fórmula: C₂₁H₁₄N₆OS₂

Pureza: 98%

Peso molecular: 430.51

Ref: 54-OR1022996

BTSA1

CAS: 314761-14-3

BTSA1

Fórmula: C₂₁H₁₄N₆OS₂

Pureza: ≥95%

Peso molecular: 430.51

Ref: 54-BUP09959

BTSA1

CAS: 314761-14-3

BTSA1: High-affinity BAX activator inducing conformational changes for apoptosis.

Fórmula: C₂₁H₁₄N₆OS₂

Pureza: 99.60% - 99.71%

Cor e Forma: Solid

Peso molecular: 430.505

Ref: TM-T5104

BTSA1

CAS: 314761-14-3

5-Phenyl-2-(4-phenylthiazol-2-yl)-4-(2-(thiazol-2-yl)hydrazono)-2,4-dihydro-3H-pyrazol-3-one

Fórmula: C₂₁H₁₄N₆OS₂

Pureza: 98%

Peso molecular: 430.51

Ref: IN-DG00813593

BTSA1

CAS: 314761-14-3

BTSA1 is a cytosolic protein that is expressed at low levels in normal cells, but can be induced to high levels in leukemic cells. BTSA1 has been shown to act as an effector protein by binding to mitochondrial superoxide and inhibiting mitochondrial membrane potential. It also inhibits the activation of caspase-9 and apoptosis pathway, which leads to apoptosis. BTSA1 has been shown to have anti-leukemic activity and may be a potential therapeutic target for cancer.

Fórmula: C₂₁H₁₄N₆OS₂

Pureza: Min. 95%

Peso molecular: 430.51 g/mol

Ref: 3D-PMA76114